Zura Bio (ZURA) News Today → Must-See: Elon’s New Invention is Absolutely Insane (From InvestorPlace) (Ad) Free ZURA Stock Alerts $5.25 -0.24 (-4.37%) (As of 05/28/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 28 at 3:14 AM | marketbeat.comZura Bio Limited (NASDAQ:ZURA) Receives Consensus Recommendation of "Buy" from AnalystsShares of Zura Bio Limited (NASDAQ:ZURA - Get Free Report) have been assigned a consensus recommendation of "Buy" from the six brokerages that are currently covering the firm, Marketbeat reports. Five research analysts have rated the stock with a buy rating and one has assigned a strong buy ratinMay 25 at 5:44 AM | americanbankingnews.comInsider Buying: Zura Bio Limited (NASDAQ:ZURA) Director Buys 80,000 Shares of StockMay 24, 2024 | msn.comZura Bio files to sell 41.6M Class A ordinary shares for holdersMay 24, 2024 | insidertrades.comZura Bio Limited (NASDAQ:ZURA) Director Acquires $496,000.00 in StockMay 24, 2024 | investorplace.com3 Penny Stocks to Buy Now: May 2024May 23, 2024 | marketbeat.comZura Bio Limited (NASDAQ:ZURA) Director Van Amstel Arnout Ploos Acquires 80,000 SharesZura Bio Limited (NASDAQ:ZURA - Get Free Report) Director Van Amstel Arnout Ploos bought 80,000 shares of the business's stock in a transaction that occurred on Friday, May 17th. The stock was acquired at an average cost of $6.20 per share, with a total value of $496,000.00. Following the completion of the acquisition, the director now owns 100,000 shares of the company's stock, valued at approximately $620,000. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.May 10, 2024 | finance.yahoo.comZura Bio Ltd (ZURA) Q1 2024 Earnings: Financial and Strategic DevelopmentsMay 10, 2024 | marketbeat.comZura Bio (NASDAQ:ZURA) Given New $21.00 Price Target at OppenheimerOppenheimer raised their target price on shares of Zura Bio from $16.00 to $21.00 and gave the company an "outperform" rating in a research note on Friday.May 9, 2024 | investorplace.comZURA Stock Earnings: Zura Bio Beats EPS for Q2 2024May 9, 2024 | finance.yahoo.comZura Bio Reports First Quarter 2024 Financial Results and Recent Business HighlightsMay 4, 2024 | msn.comPiper Sandler Initiates Coverage of Zura Bio (ZURA) with Overweight RecommendationMay 3, 2024 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Irhythm Technologies (IRTC), Zura Bio (ZURA)May 3, 2024 | marketbeat.comZura Bio Limited (NASDAQ:ZURA) Given Consensus Rating of "Buy" by BrokeragesZura Bio Limited (NASDAQ:ZURA - Get Free Report) has received a consensus rating of "Buy" from the six analysts that are covering the stock, Marketbeat Ratings reports. Five analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 12 moMay 3, 2024 | marketbeat.comZura Bio (NASDAQ:ZURA) Research Coverage Started at Piper SandlerPiper Sandler began coverage on shares of Zura Bio in a research report on Friday. They issued an "overweight" rating and a $26.00 price objective on the stock.May 1, 2024 | finance.yahoo.comZura Bio Limited (ZURA)April 28, 2024 | 247wallst.comThese Biotechs and IPOs Inspire Big Insider BuyingApril 26, 2024 | investing.comZura Bio executive acquires $24,999 in company sharesApril 26, 2024 | investing.comZura Bio EVP Kiran Nistala buys $10,000 in company sharesApril 25, 2024 | insidertrades.comKiran Nistala Buys 3,195 Shares of Zura Bio Limited (NASDAQ:ZURA) StockApril 25, 2024 | finance.yahoo.comDirector Amit Munshi Acquires 159,744 Shares of Zura Bio Ltd (ZURA)April 24, 2024 | marketbeat.comZura Bio Limited (NASDAQ:ZURA) EVP Kiran Nistala Buys 3,195 SharesZura Bio Limited (NASDAQ:ZURA - Get Free Report) EVP Kiran Nistala purchased 3,195 shares of the stock in a transaction on Monday, April 22nd. The shares were bought at an average cost of $3.13 per share, for a total transaction of $10,000.35. Following the transaction, the executive vice president now directly owns 3,195 shares in the company, valued at $10,000.35. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.April 20, 2024 | msn.comZura Bio stock jumps on plans to raise $112.5M in private financingApril 18, 2024 | markets.businessinsider.comZura Bio Announces Private Placement Of $112 MLn Of Class A Shares; Stock UpApril 18, 2024 | marketwatch.comZura Bio Shares Rise 16% After Private Placement Valued at $112.5MApril 18, 2024 | finance.yahoo.comZura Bio Announces Oversubscribed $112.5 Million Private PlacementApril 8, 2024 | businesswire.comZura Bio Announces Robert Lisicki as CEO and DirectorApril 3, 2024 | benzinga.comZura Bio Stock (NASDAQ:ZURA), Analyst Ratings, Price Targets, PredictionsApril 2, 2024 | finance.yahoo.comInsider Buyers At Zura Bio Recover Some Losses, But Still Down US$165kMarch 31, 2024 | finance.yahoo.comZura Bio Ltd (ZURA) Reports Full Year 2023 Financial Results Amidst Leadership TransitionMarch 28, 2024 | businesswire.comZura Bio Reports Full Year 2023 Financial Results, Business Highlights, and Appoints Robert Lisicki as Chief Executive OfficerMarch 4, 2024 | businesswire.comZura Bio Announces Participation at March ConferencesMarch 3, 2024 | marketbeat.comArmistice Capital LLC Has $10.43 Million Position in Zura Bio Limited (NASDAQ:ZURA)Armistice Capital LLC increased its position in Zura Bio Limited (NASDAQ:ZURA - Free Report) by 66.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,580,000 shares of the company's stock after buying anFebruary 18, 2024 | marketbeat.comSilverarc Capital Management LLC Acquires 244,040 Shares of Zura Bio Limited (NASDAQ:ZURA)Silverarc Capital Management LLC grew its holdings in shares of Zura Bio Limited (NASDAQ:ZURA - Free Report) by 152.5% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 404,040 shares of the company's stock after buyFebruary 15, 2024 | marketbeat.comZura Bio Limited (NASDAQ:ZURA) Sees Large Decline in Short InterestZura Bio Limited (NASDAQ:ZURA - Get Free Report) was the recipient of a significant decline in short interest in the month of January. As of January 31st, there was short interest totalling 328,500 shares, a decline of 6.9% from the January 15th total of 352,900 shares. Based on an average daily trading volume, of 197,100 shares, the short-interest ratio is currently 1.7 days. Currently, 1.6% of the company's stock are short sold.February 14, 2024 | finance.yahoo.comWe're Not Very Worried About Zura Bio's (NASDAQ:ZURA) Cash Burn RateFebruary 3, 2024 | msn.comZura Bio Issues Regulation FD Disclosure StatementFebruary 2, 2024 | finance.yahoo.comZura Bio Announces Participation at February Investor ConferencesJanuary 8, 2024 | msn.comZura Bio appoints industry veteran Robert Lisicki as President and COOJanuary 8, 2024 | finance.yahoo.comZura Bio Continues to Strengthen Leadership with Appointment of Robert Lisicki as President and Kiran Nistala as CMOJanuary 3, 2024 | finance.yahoo.comZura Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference and Dermatology SummitDecember 31, 2023 | marketbeat.comZura Bio Limited (NASDAQ:ZURA) Sees Large Growth in Short InterestZura Bio Limited (NASDAQ:ZURA - Get Free Report) saw a significant growth in short interest during the month of December. As of December 15th, there was short interest totalling 215,900 shares, a growth of 24.8% from the November 30th total of 173,000 shares. Based on an average daily volume of 156,000 shares, the days-to-cover ratio is currently 1.4 days. Currently, 1.1% of the company's shares are short sold.December 4, 2023 | finance.yahoo.comZura Bio Announces Two Immunology Abstracts Presented at the World Allergy Congress in BangkokNovember 14, 2023 | finance.yahoo.comZura Bio Appoints Arnout Ploos van Amstel to its Board of DirectorsNovember 13, 2023 | msn.comZura Bio GAAP EPS of -$0.18November 13, 2023 | finance.yahoo.comZura Bio Reports Third Quarter 2023 Financial Results and Recent Business HighlightsOctober 11, 2023 | msn.comLadenburg Thalmann Initiates Coverage of Zura Bio Ltd - (ZURA) with Buy RecommendationSeptember 12, 2023 | finance.yahoo.comZura Bio Enters into Sponsored Research Agreement with Benaroya Research InstituteSeptember 7, 2023 | barrons.comZura Bio Ltd. WtSeptember 7, 2023 | finance.yahoo.comWe're Hopeful That Zura Bio (NASDAQ:ZURA) Will Use Its Cash WiselyAugust 25, 2023 | msn.comOppenheimer starts Zura Bio at outperform, cites potential of ZB-106 Get Zura Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ZURA and its competitors with MarketBeat's FREE daily newsletter. Email Address Must-See: Elon’s New Invention is Absolutely Insane (Ad)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone. Click here for the full story… ZURA Media Mentions By Week ZURA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZURA News Sentiment▼1.340.91▲Average Medical News Sentiment ZURA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZURA Articles This Week▼81▲ZURA Articles Average Week Get Zura Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ZURA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CHRS News IPHA News AGEN News ABOS News CMPX News GLUE News IVVD News INMB News MGX News ADAP News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ZURA) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesElon’s New Device is About to Shock the WorldInvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for AIWeiss RatingsThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaDigitizing the $11T commodities sector with one tiny stockResource Stock DigestMusk, Bezos, and Gates All On Board… Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zura Bio Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
